Harmony Biosciences Holdings Inc (NAS:HRMY)
$ 34.2 -0.52 (-1.5%) Market Cap: 1.95 Bil Enterprise Value: 1.75 Bil PE Ratio: 16.21 PB Ratio: 3.27 GF Score: 65/100

Harmony Biosciences Holdings Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 07:50PM GMT
Release Date Price: $32.64 (-0.43%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Well, good afternoon, everyone. Welcome to the 3:50 p.m. session on day 3 of the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and European biopharma names for the firm, and it's my great pleasure to be hosting Harmony Biosciences in a fireside chat discussion today.

And joining us from the company, CEO, John Jacobs; and CFO, Sandip Kapadia. Welcome, gentlemen. It's good to see you.

John Charles Jacobs
Harmony Biosciences Holdings, Inc. - President, CEO & Director

Thank you, Graig. Same here.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Great. I think a great place to start is just kind of maybe, John, you telling us a little bit more about the Harmony story. A relatively new company and a new publicly traded

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot